Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection

Name: Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
License: Public Domain

Archivel Farma S.L.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

tuberculosis

latent tuberculosis infection, tuberculosis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 353349
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.